These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30255515)

  • 1. Solitary facial cutaneous chronic inflammatory lesions induced by anti-tumour necrosis factor-α antagonist.
    Haro-Gabaldón V; Ruiz Molina I; Haro-González-Vico V; Solís García E
    Clin Exp Dermatol; 2019 Jan; 44(1):80-82. PubMed ID: 30255515
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistent neutrophilic scarring alopecia triggered by anti-TNF blockade for Crohn's disease.
    Amschler K; Mc Broekaert S; Mohr J; Schön MP; Mößner R
    Eur J Dermatol; 2018 Jun; 28(3):403-405. PubMed ID: 29976546
    [No Abstract]   [Full Text] [Related]  

  • 3. Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effect.
    Iborra M; Beltrán B; Bastida G; Aguas M; Nos P
    J Crohns Colitis; 2011 Apr; 5(2):157-61. PubMed ID: 21453886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case of psoriasiform and pustular eruptions in addition to alopecia as a paradoxical reaction induced by infliximab.
    Shimokata M; Namiki T; Tokoro S; Ugajin T; Miura K; Yokozeki H
    J Dermatol; 2018 Dec; 45(12):e331-e333. PubMed ID: 29855072
    [No Abstract]   [Full Text] [Related]  

  • 5. Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: a 14-year experience.
    Fréling E; Baumann C; Cuny JF; Bigard MA; Schmutz JL; Barbaud A; Peyrin-Biroulet L
    Am J Gastroenterol; 2015 Aug; 110(8):1186-96. PubMed ID: 26195181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exfoliative erythroderma after tumor necrosis factor-α inhibitor therapy.
    el-Azhary RA; Lehman JS
    Int J Dermatol; 2016 Apr; 55(4):e214-5. PubMed ID: 26917358
    [No Abstract]   [Full Text] [Related]  

  • 7. Pustular lesions in patients with Crohn disease and treatment with tumour necrosis factor-α inhibitors.
    Balaguer-Franch I; Hernández de la Torre-Ruiz E; Lacasta-Plasin C; García-Piqueras P; Menchén-Viso L; Baniandrés-Rodríguez O
    Clin Exp Dermatol; 2022 Feb; 47(2):453-455. PubMed ID: 34431537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriasiform and pustular eruption induced by infliximab.
    Takahashi H; Hashimoto Y; Ishida-Yamamoto A; Ashida T; Kohgo Y; Iizuka H
    J Dermatol; 2007 Jul; 34(7):468-72. PubMed ID: 17584325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriasis and Psoriasiform Eruptions in Pediatric Patients with Inflammatory Bowel Disease Treated with Anti-Tumor Necrosis Factor Alpha Agents.
    Eickstaedt JB; Killpack L; Tung J; Davis D; Hand JL; Tollefson MM
    Pediatr Dermatol; 2017 May; 34(3):253-260. PubMed ID: 28211161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous Pseudolymphoma in a Patient With Crohn's Disease Under Infliximab: First Report.
    Carvalhana S; Gonçalves A; Velosa J
    J Clin Gastroenterol; 2016; 50(5):436-7. PubMed ID: 26974759
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of anti-tumour necrosis factor-induced skin lesions reveals strong T helper 1 activation with some distinct immunological characteristics.
    Stoffel E; Maier H; Riedl E; Brüggen MC; Reininger B; Schaschinger M; Bangert C; Guenova E; Stingl G; Brunner PM
    Br J Dermatol; 2018 May; 178(5):1151-1162. PubMed ID: 29143979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pigmented lichenoid drug eruption: a new clinical presentation of interface dermatitis induced by anti-TNF alpha drugs.
    Darrigade AS; Goussot JF; Milpied B; Taieb A; Seneschal J
    Eur J Dermatol; 2016 Dec; 26(6):633-634. PubMed ID: 27634463
    [No Abstract]   [Full Text] [Related]  

  • 13. Adalimumab-induced psoriasis in a patient with Crohn's disease.
    Korkmaz U; Duman AE; Dindar G; Yilmaz H; Dursun IH; Celebi A; Senturk O; Hulagu S
    Indian J Gastroenterol; 2013 Mar; 32(2):135-6. PubMed ID: 23151897
    [No Abstract]   [Full Text] [Related]  

  • 14. Sarcoidosis-Like Lesions: Another Paradoxical Reaction to Anti-TNF Therapy?
    Decock A; Van Assche G; Vermeire S; Wuyts W; Ferrante M
    J Crohns Colitis; 2017 Mar; 11(3):378-383. PubMed ID: 27591675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Henoch-Schönlein purpura during anti-TNFα therapy: a fortuitous event or an indication to stop therapy?
    Pinheiro RR; Lencastre A
    Eur J Dermatol; 2017 Jun; 27(3):304-305. PubMed ID: 28468732
    [No Abstract]   [Full Text] [Related]  

  • 16. Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study.
    Guerra I; Pérez-Jeldres T; Iborra M; Algaba A; Monfort D; Calvet X; Chaparro M; Mañosa M; Hinojosa E; Minguez M; Ortiz de Zarate J; Márquez L; Prieto V; García-Sánchez V; Guardiola J; Rodriguez GE; Martín-Arranz MD; García-Tercero I; Sicilia B; Masedo Á; Lorente R; Rivero M; Fernández-Salazar L; Gutiérrez A; Van Domselaar M; López-SanRomán A; Ber Y; García-Sepulcre M; Ramos L; Bermejo F; Gisbert JP;
    Inflamm Bowel Dis; 2016 Apr; 22(4):894-901. PubMed ID: 26933750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin Manifestations in Pediatric Patients Treated With a TNF-Alpha Inhibitor for Inflammatory Bowel Disease: A Retrospective Study [Formula: see text].
    Cossio ML; Genois A; Jantchou P; Hatami A; Deslandres C; McCuaig C
    J Cutan Med Surg; 2020; 24(4):333-339. PubMed ID: 32527153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNFα and IL-17A are differentially expressed in psoriasis-like vs eczema-like drug reactions to TNFα antagonists.
    Deubelbeiss C; Kolios AGA; Anzengruber F; French LE; Yawalkar N; Kempf W; Kerl K; Meier B; Navarini AA
    J Cutan Pathol; 2018 Jan; 45(1):23-28. PubMed ID: 29023827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Blepharitis and Ectropion With Tumor Necrosis Factor α Inhibitor Treatment in Crohn Disease.
    Teo HMT; de Sá Freire F; Demirci H
    JAMA Ophthalmol; 2019 Feb; 137(2):232-233. PubMed ID: 30419086
    [No Abstract]   [Full Text] [Related]  

  • 20. Rash induced by anti-tumor necrosis factor agents in an adolescent with Crohn's disease.
    Conklin LS; Cohen B; Wilson L; Cuffari C; Oliva-Hemker M
    Nat Rev Gastroenterol Hepatol; 2010 Mar; 7(3):174-7. PubMed ID: 20203680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.